4.5 Article

Limitations of mouse models for sickle cell disease conferred by their human globin transgene configurations

Related references

Note: Only part of the references are listed.
Article Medicine, General & Internal

Biologic and Clinical Efficacy of LentiGlobin for Sickle Cell Disease

Julie Kanter et al.

Summary: The LentiGlobin gene therapy for sickle cell disease showed promising results, with significant improvements in hemoglobin levels and complete resolution of severe vaso-occlusive events in 35 patients. Adverse events related to treatment were minimal and no cases of hematologic cancer were observed during the follow-up period. Preliminary findings suggest the potential therapeutic efficacy of this treatment.

NEW ENGLAND JOURNAL OF MEDICINE (2022)

Article Medicine, General & Internal

Post-Transcriptional Genetic Silencing of BCL11A to Treat Sickle Cell Disease

Erica B. Esrick et al.

Summary: This study confirms BCL11A inhibition as an effective approach for inducing HbF in sickle cell disease. Preliminary evidence suggests that shmik-based gene knockdown offers a favorable risk-benefit profile in treating sickle cell disease.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

CRISPR-Cas9 Gene Editing for Sickle Cell Disease and β-Thalassemia

H. Frangoul et al.

Summary: Research utilizing CRISPR-Cas9 technology for gene editing in patients with TDT and SCD showed high levels of edited alleles in bone marrow and blood, leading to partial or complete elimination of symptoms.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Multidisciplinary Sciences

Cas9-AAV6 gene correction of beta-globin in autologous HSCs improves sickle cell disease erythropoiesis in mice

Adam C. Wilkinson et al.

Summary: CRISPR mediated gene correction in patient-derived hematopoietic stem cells for sickle cell disease is a promising therapy. Researchers utilized a humanized SCD mouse model to study gene editing in the context of autologous transplantation.

NATURE COMMUNICATIONS (2021)

Article Biology

3′HS1 CTCF binding site in human β-globin locus regulates fetal hemoglobin expression

Pamela Himadewi et al.

Summary: Deletion of the CTCF binding site 3' HS1 in the adult beta-globin gene locus can induce fetal hemoglobin expression, potentially offering therapeutic implications for treating hemoglobinopathies. This induction is mediated by ectopic access of a distal enhancer in the OR52A1 gene, which can be insulated by the inversion of the 3' HS1 CTCF site.

ELIFE (2021)

Article Pharmacology & Pharmacy

Olinciguat, a stimulator of soluble guanylyl cyclase, attenuates inflammation, vaso-occlusion and nephropathy in mouse models of sickle cell disease

Boris Tchernychev et al.

Summary: The sGC stimulator olinciguat attenuates inflammation, vaso-occlusion, and kidney injury in mouse models of SCD and systemic inflammation. Co-treatment with hydroxyurea enhances the anti-inflammatory effect of olinciguat, showing a potential beneficial impact on disease progression.

BRITISH JOURNAL OF PHARMACOLOGY (2021)

Article Genetics & Heredity

Chromothripsis as an on-target consequence of CRISPR-Cas9 genome editing

Mitchell L. Leibowitz et al.

Summary: CRISPR-Cas9 editing can result in nuclear structural defects, formation of micronuclei and chromosome bridges, leading to a mutational process known as chromothripsis. Chromothripsis, extensive chromosome rearrangement restricted to one or a few chromosomes, can cause human congenital disease and cancer. The potential for extensive chromosomal rearrangements should be considered and monitored as genome editing is implemented in the clinic.

NATURE GENETICS (2021)

Article Hematology

FT-4202, an oral PKR activator, has potent antisickling effects and improves RBC survival and Hb levels in SCA mice

Archana Shrestha et al.

Summary: The study demonstrated the effectiveness of FT-4202 in Berkeley SCA mice, showing a reduction in HbS P-50 levels, decreased sickling, improved RBC deformability, increased RBC survival, and elevated Hb levels.

BLOOD ADVANCES (2021)

Article Multidisciplinary Sciences

Base editing of haematopoietic stem cells rescues sickle cell disease in mice

Gregory A. Newby et al.

Summary: The study demonstrated successful conversion of sickle cell disease allele into a non-pathogenic variant using adenine base editor, with durable therapeutic effects. The edited HSPCs improved physiological parameters and reduced pathological abnormalities in spleens of mice, indicating the potential for long-lasting and effective treatment for SCD.

NATURE (2021)

Article Genetics & Heredity

Activation of γ-globin gene expression by GATA1 and NF-Y in hereditary persistence of fetal hemoglobin

Phillip A. Doerfler et al.

Summary: Hereditary persistence of fetal hemoglobin variants activate gamma-globin expression through distinct mechanisms involving transcription factors, providing insights for therapeutic genome editing and gene therapies targeting this element.

NATURE GENETICS (2021)

Article Biochemistry & Molecular Biology

Enabling large-scale genome editing at repetitive elements by reducing DNA nicking

Cory J. Smith et al.

NUCLEIC ACIDS RESEARCH (2020)

Review Medicine, Research & Experimental

Emerging Genetic Therapy for Sickle Cell Disease

Stuart H. Orkin et al.

ANNUAL REVIEW OF MEDICINE, VOL 70 (2019)

Review Medicine, Research & Experimental

Genetic engineering of hematopoiesis: current stage of clinical translation and future perspectives

Luigi Naldini

EMBO MOLECULAR MEDICINE (2019)

Article Hematology

Genome editing of HBG1 and HBG2 to induce fetal hemoglobin

Jean-Yves Metais et al.

BLOOD ADVANCES (2019)

Article Multidisciplinary Sciences

CRIS.py: A Versatile and High-throughput Analysis Program for CRISPR-based Genome Editing

Jon P. Connelly et al.

SCIENTIFIC REPORTS (2019)

Article Biochemistry & Molecular Biology

Direct Promoter Repression by BCL11A Controls the Fetal to Adult Hemoglobin Switch

Nan Liu et al.

Article Biochemistry & Molecular Biology

p53 inhibits CRISPR-Cas9 engineering in human pluripotent stem cells

Robert J. Ihry et al.

NATURE MEDICINE (2018)

Article Biochemistry & Molecular Biology

CRISPR-Cas9 genome editing induces a p53-mediated DNA damage response

Emma Haapaniemi et al.

NATURE MEDICINE (2018)

Review Oncology

Hematopoietic stem cell transplantation for sickle cell disease: Progress and challenges

Monica L. Hulbert et al.

PEDIATRIC BLOOD & CANCER (2018)

Article Multidisciplinary Sciences

A Survey of Validation Strategies for CRISPR-Cas9 Editing

Monica F. Sentmanat et al.

SCIENTIFIC REPORTS (2018)

Article Medicine, General & Internal

Sickle cell disease

Gregory J. Kato et al.

NATURE REVIEWS DISEASE PRIMERS (2018)

Article Biotechnology & Applied Microbiology

Gene Therapy for Sickle Cell Disease: A Lentiviral Vector Comparison Study

Fabrizia Urbinati et al.

HUMAN GENE THERAPY (2018)

Article Biochemistry & Molecular Biology

A limited number of double-strand DNA breaks is sufficient to delay cell cycle progression

Jeroen van den Berg et al.

NUCLEIC ACIDS RESEARCH (2018)

Review Genetics & Heredity

Wake-up Sleepy Gene: Reactivating Fetal Globin for beta-Hemoglobinopathies

Beeke Wienert et al.

TRENDS IN GENETICS (2018)

Article Multidisciplinary Sciences

Programmable base editing of A.T to G.C in genomic DNA without DNA cleavage

Nicole M. Gaudelli et al.

NATURE (2017)

Review Medicine, General & Internal

Sickle Cell Disease

Frederic B. Piel et al.

NEW ENGLAND JOURNAL OF MEDICINE (2017)

Review Biochemistry & Molecular Biology

p21: A Two-Faced Genome Guardian

Alexandros G. Georgakilas et al.

TRENDS IN MOLECULAR MEDICINE (2017)

Review Biochemistry & Molecular Biology

The regulation of human globin promoters by CCAAT box elements and the recruitment of NF-Y

Gabriella E. Martyn et al.

BIOCHIMICA ET BIOPHYSICA ACTA-GENE REGULATORY MECHANISMS (2017)

Article Hematology

Treating sickle cell disease by targeting HbS polymerization

William A. Eaton et al.

BLOOD (2017)

Article Medicine, Research & Experimental

Lineage-specific BCL11A knockdown circumvents toxicities and reverses sickle phenotype

Christian Brendel et al.

JOURNAL OF CLINICAL INVESTIGATION (2016)

Article Biotechnology & Applied Microbiology

CRISPR/Cas9-Mediated Correction of the Sickle Mutation in Human CD34+ cells

Megan D. Hoban et al.

MOLECULAR THERAPY (2016)

Article Multidisciplinary Sciences

CRISPR/Cas9 β-globin gene targeting in human haematopoietic stem cells

Daniel P. Dever et al.

NATURE (2016)

Article Multidisciplinary Sciences

Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage

Alexis C. Komor et al.

NATURE (2016)

Article Biochemical Research Methods

Real-time selective sequencing using nanopore technology

Matthew Loose et al.

NATURE METHODS (2016)

Article Biochemistry & Molecular Biology

deepTools2: a next generation web server for deep-sequencing data analysis

Fidel Ramirez et al.

NUCLEIC ACIDS RESEARCH (2016)

Article Biotechnology & Applied Microbiology

The Oxford Nanopore MinION: delivery of nanopore sequencing to the genomics community

Miten Jain et al.

GENOME BIOLOGY (2016)

Article Multidisciplinary Sciences

Amelioration of inflammation and tissue damage in sickle cell model mice by Nrf2 activation

Nadine Keleku-Lukwete et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2015)

Article Biochemical Research Methods

Skewer: a fast and accurate adapter trimmer for next-generation sequencing paired-end reads

Hongshan Jiang et al.

BMC BIOINFORMATICS (2014)

Article Biotechnology & Applied Microbiology

Targeted sequencing by proximity ligation for comprehensive variant detection and local haplotyping

Paula J. P. de Vree et al.

NATURE BIOTECHNOLOGY (2014)

Review Cell Biology

Chromothripsis and beyond: rapid genome evolution from complex chromosomal rearrangements

Cheng-Zhong Zhang et al.

GENES & DEVELOPMENT (2013)

Article Medicine, Research & Experimental

The Switch from Fetal to Adult Hemoglobin

Vijay G. Sankaran et al.

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2013)

Article Biochemistry & Molecular Biology

p21 promotes error-free replication-coupled DNA double-strand break repair

Maurizio Mauro et al.

NUCLEIC ACIDS RESEARCH (2012)

Article Medicine, Research & Experimental

Evolution of Hemoglobin and Its Genes

Ross C. Hardison

COLD SPRING HARBOR PERSPECTIVES IN MEDICINE (2012)

Article Biochemical Research Methods

BigWig and BigBed: enabling browsing of large distributed datasets

W. J. Kent et al.

BIOINFORMATICS (2010)

Article Biochemical Research Methods

Fast and accurate long-read alignment with Burrows-Wheeler transform

Heng Li et al.

BIOINFORMATICS (2010)

Article Biochemical Research Methods

BEDTools: a flexible suite of utilities for comparing genomic features

Aaron R. Quinlan et al.

BIOINFORMATICS (2010)

Article Multidisciplinary Sciences

Double-strand breaks associated with repetitive DNA can reshape the genome

Juan Lucas Argueso et al.

PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)

Article Biochemical Research Methods

Comparative Genomics search for losses of long-established genes on the human lineage

Jingchun Zhu et al.

PLOS COMPUTATIONAL BIOLOGY (2007)

Review Hematology

Locus control regions

QL Li et al.

BLOOD (2002)

Article Multidisciplinary Sciences

Correction of sickle cell disease in transgenic mouse models by gene therapy

R Pawliuk et al.

SCIENCE (2001)

Article Biochemistry & Molecular Biology

Genome scan identifies a locus affecting gamma-globin level in human beta-cluster YAC transgenic mice

SD Lin et al.

MAMMALIAN GENOME (2000)